在小鼠实验模型中,d-cycloserine对COPD和抑郁症的影响
Uriel Heresco-Levy1,2, Jacob Haviv1, Yehezkel G Caine1
1Herzog Medical Center, Jerusalem, Israel.
Frontiers in pharmacology
|June 16, 2025
概括
在慢性阻塞性肺病 (COPD) 的小鼠模型中,d-cycloserine (DCS) 减少了肺损伤和类似抑郁症的行为. 这些发现表明,DCS可能是治疗COPD和抑郁症的新疗法.
科学领域:
- 肺部医学 肺部医学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 和抑郁症与慢性炎症有着共同的联系,呈现出重大未满足的临床需求.
- N-甲基-D-酸盐谷物质受体 (NMDAR) 通过促炎信号和氧化应激作用,与肺损伤和抑郁有关.
- 作为一种NMDAR抗体的D-环素 (DCS),具有抗抑郁和抗炎性质.
研究的目的:
- 调查NMDAR下调作为治疗COPD-抑郁症并发症的统一分子标.
- 在小鼠COPD模型中评估DCS在改善肺损伤和类似抑郁症的行为方面的有效性.
主要方法:
- 一种猪胰腺弹性酶 (PPE) /E. 大肠杆菌脂多聚糖化物 (LPS) 模型被用于诱导雄性BALB/c小鼠的COPD.
- 小鼠接受了PPE和LPS内,随后是载体或DCS (100或200毫克/公斤) 的腹腔内给药.
- 使用强迫游泳测试 (FST) 评估了类似抑郁症的行为,并通过组织病理学分析了肺部组织.
主要成果:
- 与对照人群相比,COPD模型表现出炎症细胞透的增加,肺气 (平均线性拦截) 和FST不运动持续时间.
- DCS治疗 (100毫克/公斤) 显著减少了FST中的不运动持续时间.
- 在各种治疗组中,DCS的使用还降低了肺炎的严重程度和平均线性截止.
结论:
- 在COPD模型中,D-cycloserine在减少肺损伤和类似抑郁症的行为方面表现出有益的影响.
- 这些发现支持进一步调查DCS作为COPD-抑郁症并发症的创新治疗剂.
相关概念视频
COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...


